Literature DB >> 7705117

Exploratory thoracotomy for nonresectable lung cancer.

S S Steinbaum1, I D Uretzky, H P McAdams, K G Torrington, A J Cohen.   

Abstract

We sought to evaluate the effect of new diagnostic modalities on patients explored surgically for inoperable lung cancer. From July 1983 to February 1992, 335 patients underwent thoracotomy for lung cancer. Thirty-three of the 35 patients with nonresectable disease had sufficient data for analysis and underwent chest radiography (CXR), CT scan, and bronchoscopy. The study was terminated when video-assisted thoracoscopy (VAT) was introduced at the institution. Causes of nonresectability included significant N2 disease not diagnosed preoperatively (n = 11), tumor invasion of contiguous mediastinal structures (n = 8), and insufficient pulmonary function (n = 4). Four patients were left with unresected disease because of thoracic metastasis. Two patients had technically unresectable disease; three patients were explored surgically because diagnoses could be obtained by no other means. One patient was found to have small cell cancer. Data analysis demonstrated that 19 of 33 thoracotomies could potentially have been avoided or resulted in resection with current techniques. Refinement of imaging criteria, a judicious surgical approach to N2 disease, and VAT may significantly reduce thoracotomies for nonresectable lung cancer.

Entities:  

Mesh:

Year:  1995        PMID: 7705117     DOI: 10.1378/chest.107.4.1058

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

1.  Unexpected extensions of non-small-cell lung cancer diagnosed during surgery: revisiting exploratory thoracotomies and incomplete resections.

Authors:  Christophe Foucault; Pierre Mordant; Bertrand Grand; Karima Achour; Alex Arame; Antoine Dujon; Françoise Le Pimpec Barthes; Marc Riquet
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-01-23

2.  Exploratory thoracotomy and its influence on the survival of patients with lung cancer.

Authors:  Lucka Debevec; Janez Erzen; Andrej Debeljak; Anton Crnjac; Viljem Kovac
Journal:  Wien Klin Wochenschr       Date:  2006-08       Impact factor: 1.704

3.  Improving surgical resection rate in lung cancer.

Authors:  C Laroche; F Wells; R Coulden; S Stewart; M Goddard; E Lowry; A Price; D Gilligan
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.